One of the areas that I have led is the integration of robotic surgery in the management of high risk and muscle invasive bladder cancer. So, in those cases, a patient's bladder may need to be removed in order to treat their cancer, and we have to perform a urinary reconstruction as a result. A key component of our program is the ability to offer a neobladder or a bladder substitute. A bladder substitute or neobladder allows a patient to maintain normal urinary function after their bladder is removed. And one of the advances that we've done with robotic surgery is to be able to do this entire complex operation without having to make a large incision. We're able to perform this complex operation through little keyhole incisions. What that does is it really helps to minimize the impact of this operation, and that allow our patients to have fewer complications to minimize their stay in the hospital and maximize their recovery after the operation.